Glenmark Pharmaceuticals Discloses Data Security Incident in Indiana

Glenmark Pharmaceuticals Inc USA, a global pharmaceutical company, has officially reported a data security incident to state regulators in Indiana. This filing confirms that unauthorized access to the company's internal systems occurred, which may have exposed sensitive personal information.

The breach date is identified as February 27, 2026. Glenmark Pharmaceuticals filed its report concerning this incident on March 17, 2026. The company is actively investigating the extent and nature of the unauthorized access to determine precisely what information was involved.

Individuals who received a direct notification letter from Glenmark Pharmaceuticals Inc USA should carefully review its contents. Such a letter indicates that your personal information may have been compromised as a result of this security event.

It is advisable for anyone affected to remain vigilant. Review statements from your financial institutions and any medical providers for suspicious activity. Consider changing passwords for online accounts, especially if you use similar credentials across multiple services.

Staying informed about official communications from Glenmark Pharmaceuticals and monitoring personal accounts are prudent steps following any data security event. This information is based on public filings made with regulatory bodies.